Glyphosate, the most widely used herbicide in U.S. row-crop production, is back under federal review — and farm groups are tracking every step for signals about whether the product stays on shelves at current labels and volumes.

The U.S. Environmental Protection Agency and the Department of Health and Human Services have expanded their agency collaboration as the pesticide moves through its mandatory 15-year labeling evaluation. The review requires regulators to re-examine the science behind the registration before deciding whether, and under what conditions, glyphosate remains available to farmers.

Elizabeth Burns-Thompson, executive director of the Modern Ag Alliance, an agriculture industry group, described the process in an interview with Brownfield Ag News. "They go back in to re-review the science and re-review" the existing registration record, she said, outlining the statutory cycle that triggers a fresh look at pesticide labels on a set schedule.

The stakes for growers are straightforward. Glyphosate sits at the base of weed-control programs across corn, soybean and other broadacre systems, where it functions as a low-cost, broad-spectrum burndown and in-crop tool. Any outcome that narrows the label — through revised use rates, additional restrictions or application buffers — would push farmers toward alternative chemistries, which typically carry higher per-acre input costs and different resistance-management profiles.

A withdrawal from the market altogether would carry even larger margin consequences, forcing wholesale reformulation of weed programs in the middle of an environment where input budgets already absorb pressure from fertilizer and crop-protection pricing.

What makes this review cycle different from prior ones is the expanded role of HHS. The health agency's deeper involvement in the evaluation reflects the interagency collaboration now formally in place, and it adds a dimension that ag groups are watching closely: how human-health considerations feed into EPA's final regulatory posture on the herbicide.

Burns-Thompson and the Modern Ag Alliance are framing the review as a moment for growers and industry to stay engaged, given that the outcome will shape product availability for the full span of the next registration period. Farm organizations have historically mobilized comment campaigns during pesticide reviews, arguing that loss of established chemistries raises costs and complicates resistance management.

The 15-year cycle itself is a structural feature of federal pesticide law, not a response to any single new finding. That distinction matters for farmers reading headlines: a scheduled re-review does not by itself signal a pending ban, but the scope of the science re-examination — and now the HHS partnership — will determine how regulators weigh the record this time around.

Agribusiness will be watching for the agencies' next procedural milestones, including opportunities for public comment, as the evaluation proceeds toward a decision that will set glyphosate's regulatory footing — and its cost profile in farm weed-control budgets — for the cycle ahead.